In a very the latest study, we reported the identification as well as the characterization of a brand new atypical opioid receptor with exceptional negative regulatory Qualities towards opioid peptides.1 Our benefits confirmed that ACKR3/CXCR7, hitherto referred to as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is additionally